Press release content from Business Wire. The AP news staff was not involved in its creation.
Repertoire Immune Medicines to Provide Progress Updates on Clinical Programs and Discovery Platform at J.P. Morgan Healthcare Conference
January 7, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Jan 7, 2021
Repertoire Immune Medicines, a clinical-stage biotech company creating a new category of immune therapies for cancer, autoimmunity and infectious disease, today announced that John Cox, Chief Executive Officer, will participate in the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 at 8:05 a.m. EST. Mr. Cox will provide an update on progress and plans for its lead clinical programs and advancement of its immune medicines platform.